Development and frontier trends of research on the gut microbiota and cholangiocarcinoma Authors: Xusheng Zhang, Hongkun Yin, Di Liu, Tao Jiao, Qi Wang Published: 2026 ABSTRACT AbstractBackgroundAlthough research on the gut microbiota and cholangiocarcinoma has developed rapidly in recent years, and the gut microbiota plays an important role in cholangiocarcinoma, there is currently a lack of comprehensive and objective understanding of the latest progress and future research directions in this field. This study comprehensively evaluated and visually analyzed this research area based on bibliometric methods.MethodsThis analysis used tools such as the “Bibliometrix” R package, VOSviewer, CiteSpace, and Microsoft Office Excel (2019 version) to comprehensively conduct a bibliometric analysis of scientific research outputs related to the gut microbiota and cholangiocarcinoma. The data analyzed were all sourced from the Web of Science Core Collection (2009–2025).ResultsA total of 124 research achievements published from 2009 to 2025 were included. Eight hundred and ninety-six researchers from 278 institutions in 37 countries/regions participated in the research on the gut microbiota and cholangiocarcinoma. The number of global publications has steadily increased, reaching a peak in 2024. China had the most publications and citations, followed by Italy and the United States. The University of Oslo, Khon Kaen University, and Università degli Studi di Palermo were the main institutions in this research area and made important contributions. Cancers, International Journal of Microorganisms, and Microorganisms were the most relevant journals in this research area. DI CARLO P, GIAMMANCO A, and SERRA N were the most relevant authors in this research area and made important contributions. The latest frontier research direction focuses on “metabolism”, aiming to further explore the pathogenesis of cholangiocarcinoma through the gut microbiota and to find new therapeutic approaches.ConclusionThis study comprehensively summarized the development of research on the gut microbiota and cholangiocarcinoma from 2009 to 2025. The research results revealed the latest research frontiers and hotspots in this field and provided valuable insights for future research. However, it should be noted that although WoSCC is a widely recognized and authoritative database, it may have limitations in terms of regional bias, language coverage, and metadata accuracy, which may affect the comprehensiveness of our analysis.Keywords: Gut microbiota, Cholangiocarcinoma, Bibliometrix, VOSviewer, CiteSpace Introduction Cholangiocarcinoma is one of the common malignant tumors in the digestive system [1], [2]. Its main risk factors include parasitic infections, primary sclerosing cholangitis, biliary cysts, gallstones, and toxins. Other less certain potential risk factors include inflammatory bowel disease (IBD), hepatitis C virus (HCV), hepatitis B virus (HBV), cirrhosis, diabetes, obesity, alcohol consumption, smoking, and host genetic polymorphisms. In addition, risk factors for cholangiocarcinoma also include older age, smoking, diabetes, and certain genetic diseases [1], [2], [3], [4], [5]. According to the “Global Cancer Statistics Report 2022”, cholangiocarcinoma, a highly malignant liver tumor originating from the biliary epithelium, has long had a very poor prognosis, with a 5-year survival rate of less than 20% [6]. Its insidious onset, rapid progression, and poor prognosis make it a significant burden on global health-care systems. China, due to the prevalence of chronic cholangitis and gallstones, is one of the main countries with a high incidence of cholangiocarcinoma, with about half of the global cases occurring in China. At present, the overall 5-year survival rate of cholangiocarcinoma is less than 10%, and its annual incidence and mortality rates are very close [7]. Studies in the United States have shown that although the survival rate of cholangiocarcinoma has improved compared with decades ago, the prognosis is still poor, far below patient expectations, and the burden remains heavy [8]. It is extremely important for the prognosis of cholangiocarcinoma to further clarify its pathogenesis and to discover new targets for diagnosis and treatment. The gut microbiota is a collection of microorganisms in the human gut, which play an important role in maintaining host health, including participating in food digestion, synthesizing vitamins, and regulating immunity [9], [10]. Dysbiosis of the gut microbiota can lead to gut microbes or their products crossing the damaged intestinal epithelial barrier into the systemic circulation, activating immune cells, which may lead to chronic cholangitis and inflammation, and eventually further lead to cancer [11]. The relationship between cholangiocarcinoma and the gut microbiota is increasingly attracting attention. Studies have shown that there are significant differences in the distribution of microbial flora in the bile of patients with cholangiocarcinoma compared with healthy people, and the imbalance of biliary microbiota may be related to the development of cholangiocarcinoma. In addition, the development of cholangiocarcinoma leads to significant metabolic changes in the gut, including changes in the relative concentrations of uracil, succinic acid, and 5-aminovaleric acid. Other studies have also shown that the gut microbiota can promote the occurrence and development of cholangiocarcinoma by regulating the recruitment of myeloid-derived suppressor cells by hepatocytes to form an immunosuppressive microenvironment. As a digestive tumor with a very poor prognosis and an increasing incidence, the relationship between cholangiocarcinoma and the gut microbiota, especially the role of bacterial retrograde infection and intestinal microbiota imbalance in the progression of cholangiocarcinoma, should be given attention. Bibliometrics is widely used because it focuses on quantifying the entire knowledge system. This paper aims to comprehensively and objectively analyze the indicators of research on cholangiocarcinoma and the gut microbiota through bibliometrics, to clarify the trends, hotspots, and directions of research in this field for researchers, and to provide new clues and ideas for future research. Materials and methods Data collection Web of Science not only contains core databases (such as SCI, SSCI, and A&HCI) but also includes the Conference Proceedings Citation Index (CPCI) and the Book Citation Index (BKCI). The data information on research related to cholangiocarcinoma and the gut microbiota used in this analysis is sourced from the Web of Science Core Collection, WoSCC: (https://webofscience.com/wos/woscc/full-). Search strategy All published papers were collected from WoSCC. Researchers retrieved relevant papers published from January 1, 2009, to May 31, 2025: TS = ((Gut microbiota) OR ((Cholangiocarcinoma) OR (Biliary tract cancer) OR (Intrahepatic cholangiocarcinoma) OR (Extrahepatic cholangiocarcinoma) OR (Hilar cholangiocarcinoma)) AND Publication Year = (2009–2025) AND document Types = (articles&reviews) AND language = (English). After the initial data retrieval, researchers screened all publications to ensure their relevance to the theme of this study. The research process is shown in the flowchart in Fig. 1. The download format was a plain text file of “Full Text and Cited References.” Flowchart of the study. Bibliometric analysis This analysis covered an overview of the total number of published papers, countries, regions, institutions, authors, journal distribution, document types, references, keywords, and trends, following a step-by-step in-depth analysis from macro to micro perspectives. Subsequently, the collected data were further analyzed using “Bibliometrix” (R version 4.4.0), VOSviewer (version 1.6.20), CiteSpace (version 6.3. R1), and Microsoft Excel (2019 version). Specifically, for the VOSviewer co-occurrence networks we set minimum occurrence thresholds of 20 for keywords, 10 for journals and 15 for authors; co-occurrence strength was normalized with the default cosine index and the top 100 high-frequency nodes were selected for visualization. In CiteSpace burst detection we used γ = 1.0, a minimum duration of 2 years, and a burst-strength cutoff of the top 5%; nodes with betweenness centrality ≥0.10 were defined as “key turning points”. The “most relevant” journals, authors and institutions were identified by combining two criteria: ① total citations (TC) ≥ 100, and ② average citations per paper (ACite) for 2020–2024 ≥ 5, retaining the top 10 ranked in descending order of ACite. Results Overall publication of global literature A total of 124 documents related to cholangiocarcinoma and the gut microbiota were finally selected from the Web of Science database, including 69 research articles and 55 reviews. Fig. 2 shows that the number of annual publications related to cholangiocarcinoma and the gut microbiota from 2011 to 2025 generally showed a fluctuating upward trend. The number was low in 2011, reached a peak in 2012, and then declined. Starting from 2009, the number gradually increased and reached the highest point in 2023, followed by a slight decline. The scientific output in 2024–2025 was lower than in previous years. Since we used the online publication time as the cut-off value and the search for relevant studies in 2025 was only up to May, the number of publications in 2025 was significantly reduced. However, it is worth noting that even though the literature search for 2025 was only up to May, the number of relevant studies had already exceeded half of that in 2024. Therefore, it is predicted that the scientific output related to this field in 2025 may be higher than in 2024. The average number of annual citations sharply increased between 2011 and 2012, reached a peak in 2013, and then quickly declined. Starting from 2014, the average number of annual citations fluctuated greatly, but the overall trend was downward, approaching zero by 2025. Trends in annual output and average annual citations of publications related to cholangiocarcinoma and the gut microbiota. Country/region analysis During the study period, a total of 5045 researchers from 1015 institutions in 34 countries/regions participated in research related to cholangiocarcinoma and the gut microbiota. The relationship between the countries/regions of scientific output based on the authors' countries of residence is shown in Fig. S1A, where China is the largest network node, indicating that China has made a leading contribution in this research field. An analysis of the cumulative annual publication output of the top-ranking countries in terms of the number of publications was conducted. The results showed that China had a scientific output of 150 publications in this research field from 2009 to 2025, far ahead of other countries. Italy ranked second with nearly 80 publications, and the United States was third (Fig. 3A). Subsequently, an analysis of the cumulative publication output over time for the top five countries in terms of publication output was conducted. The results showed that, overall, the number of articles published by each country from 2009 to 2025 increased significantly. China had the most pronounced growth trend, with a continuous increase in growth rate after 2019, reaching a peak in 2024. This may be due to the fact that the literature search for 2025 was only up to May 31. The output of the United States also increased significantly after 2018, but the growth rate was slightly lower than that of China. By 2024, the output of the United States was expected to be close to 100 publications. The output of Italy also increased significantly after 2018. The output of Germany and Thailand began to increase after 2018, but the growth rate was relatively slow (Fig. 3B). In addition, the citation situation of different countries was also analyzed. The results showed that the United States had the most citations, with 1339 citations. China was second with 816 citations, and the number of citations in other countries decreased in turn (Fig. 3C). Analysis of countries/regions. (A) Scientific output by country; (B) cumulative line chart of annual scientific output of the top five publishing countries; (C) bubble chart of citation analysis by country; (D) scientific cooperation between different countries. The scientific cooperation between different countries was also explored. The results showed that cooperation between some major economies and technological powers was very close. For example, cooperation between North America (mainly the United States) and Europe (mainly the United Kingdom, Germany, and France) was very close, and cooperation between East Asian regions (mainly China, Japan, and South Korea) was also very close. In contrast, cooperation between some developing countries and smaller countries was relatively less. This cooperation network reflects the current situation and trends of global economic and technological cooperation (Fig. 3D). Analysis of institutions Subsequently, we analyzed the institutions involved in publishing research related to cholangiocarcinoma and gut microbiota. First, a cooperation network between institutions was drawn, as shown in Fig. 4A. In the figure, some larger nodes can be seen, such as “Zhejiang Shuren univ”, “Wenzhou Medical univ”, “University of Oslo” and “Oslo univ hosp”. These institutions are more active in the cooperation network and have more cooperative relationships with other institutions. They are likely to be the main research institutions in this field, with high academic influence. Moreover, the cooperation between these institutions plays an important role in the exchange and dissemination of knowledge, promoting the development of academic research. Next, this study also explored the institutions most relevant to the topic. The top ten institutions are shown in the bubble chart in Fig. 4B. It can be seen that the University of Oslo is the institution with the most publications in this research field, ranking first with 21 articles, showing its strong research strength in this field. Khon Kaen University and Università degli Studi di Palermo follow closely, each publishing 15 articles and ranking second. Other institutions, such as the National Hospital of Norway, Shanghai Jiao Tong University, the University of California system, and Wenzhou Medical University, also show strong research capabilities. Analysis of institutions. (A) Network of collaboration between institutions involved in research related to cholangiocarcinoma and gut microbiota; (B) bubble chart of the most relevant institutions involved in research related to cholangiocarcinoma and gut microbiota; (C) trends in the number of publications of the top five relevant academic institutions from 2009 to 2025. Subsequently, the study analyzed the changes in scientific output of the top five relevant academic institutions from 2009 to 2025. The results show that, overall, the article output of these institutions has increased significantly after 2015. 2023 was a peak year for the number of articles published by most institutions, and it is expected that 2025 will continue to maintain a high level. This indicates that the research activity and influence of these institutions in this field are increasing year by year, and they are likely to continue this growth trend in the next few years (Fig. 4C). Journal distribution Next, we explored the research output from the perspective of the sources of scientific output. First, we investigated the citation relationships between different academic journals. Through the size of nodes, the thickness of connections, and the colors, it is intuitive to see which journals have a greater influence in the academic community and which journals have close citation relationships. The results show that journals such as International Journal of Molecular Sciences, Cancers, and Frontiers in Microbiology have frequent citation relationships with other journals and are important contributing journals in this research field (Fig. S1B). Subsequently, we explored the relationships of co - co-citation sources. The results show that journals such as “Gastroenterology”, “Hepatology”, “Gut”, “Cancers” and “Cell” have higher centrality in the co - citation network and have more co - citation relationships with other journals, indicating that these journals have greater influence in this research field (Fig. S1C). According to Bradford's Law, the core journals related to this research field were screened. The results show that Cancers, International Journal of Molecular Sciences, and Microorganisms are the most relevant journals in this research field and have an important impact on it (Fig. 5A). The cumulative number of publications of the top five academic journals from 2009 to 2025 is shown in Fig. 5B. It can be seen that the cumulative number of publications of all journals has increased significantly after 2017. The years 2023–2024 were the peak years for the number of publications of most journals, and it is expected that 2025 will continue to maintain a high level. This indicates that the research activity and influence of these journals in the field of research related to cholangiocarcinoma and gut microbiota are increasing year by year, and they are likely to continue this growth trend in the next few years. Next, this analysis also explored the local influence of each journal. The results show that, under the assessment of H-index and G-index, Cancers, International Journal of Molecular Sciences, and Microorganisms ranked the top three in local influence, respectively. Since the evaluation system of M-index is slightly different from the former two, the local influence ranking under M-index is slightly different (details are shown in Table 1). Next, this analysis also explored the local citation of journals from 2009 to 2025. The results show that Hepatology, with 662 citations, ranked first in local citation, followed by Journal of Hepatology and GUT. This indicates that the relevant studies published in these journals have been recognized by more researchers and have played an important role in the development of this research field (Fig. 5C). Subsequently, the top 15 journals with citation bursts during the research period were analyzed. The results show that most journals had a significant increase in citations around 2010 and continued until after 2016. The recent (starting in 2022) citation burst intensity is also high and is expected to continue until 2024. These journals experienced a significant increase in citations during this period, indicating that the research they published during a specific period has attracted widespread attention from the academic community (Fig. 5D). Journal distribution. (A) Core journals in this research field selected based on Bradford's Law; (B) cumulative line chart of scientific output over time for the top five relevant journals from 2009 to 2025; (C) analysis of the most locally cited journals; (D) top 15 academic journals with citation bursts from 2009 to 2025. Table 1The local impact of sources.SourceH_indexG_indexM_indexTCNPCancers671.5787International Journal of Molecular Sciences570.7141197Microorganisms560.6254356Frontiers in Cellular and Infection Microbiology340.6614Frontiers in Microbiology341334Hepatology330.51513Nutrients330.75733World Journal of Gastroenterology330.2731333British Journal of Cancer220.21662Current Opinion in Gastroenterology220.251492Expert Review of Gastroenterology & Hepatology220.286362Frontiers in Pharmacology220.5162Gut Microbes220.3334252Journal of Clinical and Translational Hepatology220.667132Scientific Reports220.333412World Journal of Gastrointestinal Oncology220.472Alimentary Pharmacology & Therapeutics110.143261American Journal of Physiology-Gastrointestinal and Liver Physiology110.2231Annals of Hepatology110.111821TC: total citation; NP: number of publications. The local impact of sources. TC: total citation; NP: number of publications. Reference analysis Subsequently, the study conducted an analysis of the literature and references involved in this research field. The citation relationships of the literature are shown in Fig. S1D, where the larger nodes of Winston (2020) and Sek (2012) may indicate higher influence in this field. An analysis of the citation situation of local literature revealed that the documents JIA XD, 2020, HEPATOLOGY, CHNG KR, 2016, EBiOMEDICINE, and CHEN BR, 2019, BIOMED RES INT were cited most frequently (Fig. 6A). The co-citation situation of references is shown in Fig. S1E. The nodes in the figure represent different academic documents, while the connections between nodes indicate that these documents have been co-cited in other literature. The results suggest that references such as “Jia XD, 2020, Hepatology”, “Chng KR, 2016, EBioMedicine”, and “Chen BR, 2019, BioMed Research International” are in more central positions and have more co-citation relationships with other references. Among them, “jia xd, 2020, hepatology” indicates that the document published by Jia et al. in 2020 in the journal Hepatology is the most locally cited reference, suggesting that this reference is widely recognized in research related to the theme of cholangiocarcinoma and gut microbiota and may be an authoritative achievement in this field at this stage (Fig. 6B). Subsequently, this study also analyzed the top 15 references with citation bursts in this research field, and the results are shown in Fig. 6C. These references once experienced citation bursts, representing higher industry recognition at a certain stage and contributing to the development of this research field. Reference analysis. (A) Analysis of local citations of documents; (B) most locally cited references; (C) top 15 references with the strongest citation bursts. Analysis of authors A total of 896 researchers participated in studies related to cholangiocarcinoma and the gut microbiota. The co-authorship network is shown in Fig. 7A, with the team of “Liu, Feng” et al. having a higher frequency of collaboration within this field. The authors most relevant to this topic are DI CARLO P, GIAMMANCO A, and SERRA N, each having published five articles related to this research area, followed by KARLSEN TH and WANG Y, both with four publications. These authors are significant contributors to this research field (Fig. 7B). The output of authors over time is shown in Fig. 7C. It can be seen that the output of most authors (DI CARLO P, GIAMMANCO A, SERRA N, CASCIO A, CHEN G, CHEN Y, DI CIAULA A, FASCIANA T) is relatively stable, with publications each year without any particularly high-yield years. KARLSEN TH had a significant high - yield year in 2019, and WANG Y had a significant high - yield year in 2021. Analysis of authors. (A) Co-authorship network; (B) bubble chart of author relevance analysis; (C) annual scientific output of authors related to the topic; (D) analysis of the most locally cited authors; (E) top 15 authors with citation bursts. The local influence of relevant authors in this field was quantified using H_index, G_index, and M_index. Due to the different evaluation methods and preferences of the three indicators, the local influence of authors varies under different indicators. Under H_index evaluation, WANG Y, CHEN G, and DI CARLO P are the top three authors in terms of local influence (other details are shown in Table 2). Table 2Authors' local impact.AuthorH_indexG_indexM_indexTCNPWang Y440.8944Chen G330.6903Di Carlo P350.375665Di Ciaula A330.3332583Fasciana T330.375643Gasbarrini A330.5373Giammanco A350.375665Karlsen TH340.2731674Ponziani FR330.5373Portincasa P330.3332583Schnabl B330.2143463Serra N350.375665Sripa B330.2311463Wang DQH330.3332583Zhang T330.51863Baba H220.2221302Baba Y220.2221302Cascio A220.583Chen J220.5422TC: total citation; NP: number of publications. Authors' local impact. TC: total citation; NP: number of publications. Subsequently, the nationality of the corresponding authors of relevant scientific output was analyzed. It was found that authors from China published the most articles. Italy ranked second, and the United States was third. Although the output of Italian and American corresponding authors in this research field is far lower than that of China, in terms of multi - country publications (MCP), Italy has a proportion of 31.6%, and the United States also has a co - authorship ratio of 25%, both of which are much higher than China's 17.5% (other details are shown in Table 3). Chinese authors' research tends to be independently completed by a single country, lacking communication with the same nationality. Subsequently, the local citation of authors was explored. The results showed that ZHANG T is the most locally cited author, with a total of 52 citations, followed by BAI WL and CHEN Y, etc., each with a total of 30 citations (Fig. 7D). This indicates that the research of these authors has been widely recognized in this research field and has been cited multiple times. In addition, this analysis also explored the authors who had citation bursts in this research field from 2009 to 2025. The results are shown in Fig. 7E, indicating that the output of these authors during a certain period has been widely recognized and cited multiple times, playing an important role in continuing the research in this field. Table 3Corresponding author's countries.CountryArticlesArticles %SCPMCPMCP %China4032.333717.5Italy1915.313631.6USA1612.912425Germany64.84233.3Korea43.23125United Kingdom43.23125Australia32.42133.3Canada32.403100France32.42133.3Norway32.4300Poland32.4300Russia32.41266.7Japan21.6200Netherlands21.602100Singapore21.602100Austria10.8100Czech Republic10.801100Greece10.8100Ireland10.801100SCP: same country publications; MCP: multi-country publications. Corresponding author's countries. SCP: same country publications; MCP: multi-country publications. Keyword and topic analysis In the keyword analysis, we found that “gut microbiota” is the most frequently occurring keyword and is the main theme of this analysis. Next, “bile - acids”, “risk”, and “cancer” also show higher frequencies of occurrence, indicating that these are also important topics in the research. Other topics such as “cholangiocarcinoma”, “dysbiosis”, “infection” and “inflammation” also have a certain level of attention in the research in this field (Fig. 8A). An analysis of the cumulative frequency of the top 10 keywords over time shows that the cumulative occurrence of most keywords has increased significantly after 2015, indicating that these keywords have received more attention in recent years' research. In particular, “Gut microbiota” has seen a marked increase in growth rate after 2018, showing a sharp rise in research interest in this area in recent years (Fig. 8B). Subsequently, looking at the topic evolution trend from 2009 to 2025, some keywords such as “Primary biliary - cirrhosis”, “Biliary - tract”, and “Biliary-tract cancer” had already attracted attention around 2015. Terms like “Gut microbiota”, “Intestinal microbiota”, “Inflammatory-bowel - disease”, and “Infection” saw a significant increase in 2019 and 2020, reflecting that the gut microbiota gradually became a research hotspot in this field. Recently, the research focus has shifted to “Metabolism”. The increase in metabolism - related research may be due to researchers' deepening understanding of the relationship between the gut microbiota and metabolic diseases and how to treat cholangiocarcinoma by regulating metabolism. Keyword analysis. (A) Keyword treemap; (B) cumulative frequency of keywords over time; (C) topic trend analysis. Discussion Cholangiocarcinoma is characterized by its insidious onset, complex etiology, and rapid disease progression [12]. Up to now, the prognosis of cholangiocarcinoma is far from satisfactory. Although the therapeutic approaches for cholangiocarcinoma have become more diversified with the progress of research and scientific technology (including surgical resection, radiotherapy, chemotherapy, targeted therapy, etc.) [13], [14], [15], the current treatment of cholangiocarcinoma is still a comprehensive treatment mainly based on surgery. The relatively high recurrence rate after surgery leads to an unsatisfactory 5-year recurrence -free survival rate for cholangiocarcinoma. Moreover, the 5-year recurrence rate (including metastasis or new primary tumors) [6], [16] after surgery for patients with cholangiocarcinoma has been reported to exceed 50%. With the advancement of therapeutic methods, the survival rate of patients with cholangiocarcinoma has improved. From 2000 to 2009, the 1 - year survival rate of patients with cholangiocarcinoma increased from about 20% to about 30%, and the 5 - year survival rate also increased from about 5% to about 10% [17], [18], [19]. However, the mortality rate of cholangiocarcinoma remains high worldwide, and cholangiocarcinoma is still one of the malignant tumors with the lowest 5-year survival rate. It is extremely important to further explore the pathogenesis of cholangiocarcinoma and the mechanisms at the level of the tumor microenvironment to improve the treatment and prognosis of cholangiocarcinoma [20], [21]. Gut microbiota analysis, by obtaining the composition and functional information of microbial communities in samples, helps to reveal the interactions between gut microbes and the host and their impact on health and disease. This is crucial for understanding the pathogenesis of gut - related diseases and developing new therapeutic strategies [9], [10]. In recent years, it has been widely used in gut health research. It has unique advantages in identifying the structure of microbial communities, exploring the associations between specific gut microbes and specific diseases, predicting functions, and developing therapeutic strategies [22]. This study conducted a bibliometric analysis in the above - mentioned research direction. The number of annual publications related to cholangiocarcinoma and gut microbiota has shown a significant upward trend since 2009. This trend not only reflects the increasing importance of gut microbiota in cholangiocarcinoma research but also indicates the great potential of this technology in oncology research. With the progress of technology and in - depth research, the recognition of the association between gut microbiota and cholangiocarcinoma is becoming more and more important. Although the literature search for 2025 was only up to May, it has already exceeded half of the relevant research in 2024, which shows that the research on the association between gut microbiota and cholangiocarcinoma is still popular. It is predicted that the scientific output related to this field in 2025 may be higher than that in 2024, which further confirms the importance and potential of the research on the association between gut microbiota and cholangiocarcinoma. Despite the increasing number of publications related to gut microbiota, the average annual citation number shows a general downward trend. This phenomenon may be due to the fact that with the maturation and wide application of gut microbiota -related research, studies may gradually shift from exploratory to applied research, which may lead to a decrease in citation numbers. Secondly, the scientific community may be shifting to new research hotspots or technologies, resulting in a reduced focus on gut microbiota. In addition, the publications in 2025 have been published for a relatively short time and have not yet had enough time to accumulate citations, which may be one of the reasons for the decline in the average annual citation number. The continuous investment, policy support, and improvement of the scientific research environment in China have enabled China to take the lead in terms of output and influence in this research field. The application of gut microbiota in this field has provided an important means for the study of the mechanism and exploration of therapeutic methods for cholangiocarcinoma. In addition, although cross - continental cooperation is frequent, regional cooperation (such as cooperation between European countries) is also quite common. However, when the output of each country is divided according to the country of the corresponding author, it is found that although China has the most output and citations in this research field, the MCP% of China is much lower than that of the United States and Italy, indicating that Chinese authors lack international cooperation and communication. It is necessary to strengthen international exchanges to promote the progress of this research field. Diversified cooperation models are conducive to the exchange and dissemination of knowledge, and the development of academic research and medical theory. In addition, although China has the most scientific output in this research field, the number of citations of Chinese research is far lower than that of the United States. This indicates that although China has a large number of scientific research results, the quality of some research results may not yet have been highly recognized by readers. Researchers should focus on improving the quality of research to win the recognition of peers. At the same time, international cooperation should be strengthened to enhance international connections and keep pace with the international frontier, so as to further improve the scientific research production capacity and quality. Institutions such as the University of Oslo, Khon Kaen University, and Università degli Studi di Palermo have performed outstandingly in research related to cholangiocarcinoma and gut microbiota, demonstrating their strong research capabilities in this field. The cooperation network between these institutions helps in the exchange and dissemination of knowledge, promoting the development of academic research. Moreover, the significant increase in the output of these institutions after 2015 coincides with the booming development of gut microbiota research, reflecting their leading advantages in this field. Future research in this area could seek cooperation with these institutions. Journals such as Cancers, International Journal of Molecular Sciences, and Microorganisms are the most relevant in this research field and have a significant impact. The cumulative number of publications in these journals has shown a marked increase around 2015–2017, indicating a clear upward trend. The significant increase in citations during this period suggests that the research published in these journals has attracted widespread attention from the academic community. The booming development of gut microbiota research after 2017 is reflected in the topic evolution trend, with most keywords peaking in 2022–2023, indicating that these topics have received widespread attention in recent years. The latest research hotspot is focused on “metabolism”, reflecting researchers' in - depth exploration of the mechanisms underlying the association between gut microbiota and the development of cholangiocarcinoma. This is also the most cutting - edge research hotspot in this field, providing new tools and ideas for the development of diagnostic and therapeutic strategies for cholangiocarcinoma. The limitations of this study are closely related to the inherent issues of using the WoSCC database. First, this analysis only included studies from the WoSCC database, excluding those indexed in Scopus or PubMed and non-English studies. This limitation may introduce bias into the results. Second, the quality of metadata in WoSCC may be inconsistent. Errors or inaccuracies in the article indexing, such as incomplete or incorrect information on authors, institutions, or citation tracking, may affect the accuracy of the bibliometric analysis and thus the reliability of the research findings. The research data for 2025, which only included data from the first half of the year, may have overlooked common phenomena in academic research, such as delayed indexing, publication lag, and citation delay, due to the short time span. Studies that gain recognition later or are published in journals with fewer citations may be underestimated in our analysis. In addition, the bibliometric analysis used in this study mainly focuses on quantitative indicators such as publication numbers and citation frequencies, without qualitative evaluation of the content and clinical significance of specific studies [23]. Therefore, our analysis is insufficient in comprehensively reflecting the depth and impact of the included scientific output. Thus, the results of this analysis should be interpreted objectively. Future studies could provide a more balanced and inclusive research perspective by integrating more comprehensive evaluation methods, including multiple databases, and addressing the current biases. Conclusion This study comprehensively analyzed the research related to cholangiocarcinoma and gut microbiota through bibliometric methods. The study revealed the research trends, main contributors, and current research focus in this field, providing valuable references for clarifying future research directions. Although limiting the analysis to studies indexed in WoSCC may introduce some bias, these findings still have important reference value. Ethics and consent to participate Not applicable. Consent to publish declarations All authors agree to the publication of this article. CRediT authorship contribution statement Xusheng Zhang: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Formal analysis. Hongkun Yin: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Di Liu: Writing – original draft, Visualization, Validation, Supervision, Software, Project administration, Methodology, Investigation. Tao Jiao: Writing – review & editing, Visualization, Supervision, Software, Project administration, Methodology, Investigation, Data curation. Qi Wang: Writing – review & editing, Visualization, Validation, Software, Project administration, Methodology, Investigation. Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Clinical trial number Not applicable. Funding Not yet determined. Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Footnotes Supplementary data to this article can be found online at https://doi.org/10.1016/j.sopen.2026.06.001. Contributor Information Tao Jiao, Email: 20561908@qq.com. Qi Wang, Email: wq-6562@163.com. Supplementary data Fig. S1 (A) Network map of countries of collaborators involved in research related to cholangiocarcinoma and gut microbiota; (B) network of citation relationships between journals; (C) network of co-citation relationships between journals; (D) NETWORK of citation relationships between documents; (E) co-citation network of references; Data availability We retrieved and downloaded the relevant data on the gut microbiota and cholangiocarcinoma from the Web of Science Core Collection, which is publicly available. The data have been submitted as required (Supplementary material 1). References Associated Data Supplementary Materials Fig. S1 (A) Network map of countries of collaborators involved in research related to cholangiocarcinoma and gut microbiota; (B) network of citation relationships between journals; (C) network of co-citation relationships between journals; (D) NETWORK of citation relationships between documents; (E) co-citation network of references; Data Availability Statement We retrieved and downloaded the relevant data on the gut microbiota and cholangiocarcinoma from the Web of Science Core Collection, which is publicly available. The data have been submitted as required (Supplementary material 1).